Vivos Therapeutics (VVOS) Net Margin Growth (1y) (2021 - 2026)
Vivos Therapeutics (VVOS) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 67.00 |
| 10 | Vivos Therapeutics | 4.96 Mn | 3.16 Mn | 2.95 Mn | 2,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,131.00 |
| Dec 31, 2025 | -10,384.00 |
| Sep 30, 2025 | -1,184.00 |
| Jun 30, 2025 | -8,362.00 |
| Mar 31, 2025 | -1,806.00 |
| Dec 31, 2024 | -36,641.00 |
| Sep 30, 2024 | -437.00 |
| Jun 30, 2024 | 11,522.00 |
| Mar 31, 2024 | -6,591.00 |
| Dec 31, 2023 | 44,254.00 |
| Sep 30, 2023 | 6,457.00 |
| Jun 30, 2023 | 429.00 |
| Mar 31, 2023 | 10,214.00 |
| Dec 31, 2022 | 1,410.00 |
| Sep 30, 2022 | -803.00 |
| Jun 30, 2022 | -7,721.00 |
| Mar 31, 2022 | -4,772.00 |
| Dec 31, 2021 | 17,743.00 |
| Sep 30, 2021 | -5,727.00 |
| Jun 30, 2021 | -3,905.00 |